Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [3598]

Protein-protein interaction activates and fuels leukaemia cell growth

Protein-protein interaction activates and fuels leukaemia cell growth

New model for vascular and brain tumour research

New model for vascular and brain tumour research

More patients with lung cancer could benefit from immunotherapy, study shows

More patients with lung cancer could benefit from immunotherapy, study shows

Afatinib a better choice for EGFR-mutated lung cancer in first-line

Afatinib a better choice for EGFR-mutated lung cancer in first-line

Immunotherapy and targeted therapy provide new options for difficult-to-treat head and neck cancer

Immunotherapy and targeted therapy provide new options for difficult-to-treat head and neck cancer

Talimogene laherparepvec approved for unresectable melanoma

Talimogene laherparepvec approved for unresectable melanoma

Five factors identify subset of patients with advanced cervical cancer who may not benefit from bevacizumab treatment

Five factors identify subset of patients with advanced cervical cancer who may not benefit from bevacizumab...

Suicide gene therapy kills prostate tumor cells

Suicide gene therapy kills prostate tumor cells

SABCS 2015: T-DM1 improved overall survival for heavily pretreated patients with HERr2-positive breast cancer

SABCS 2015: T-DM1 improved overall survival for heavily pretreated patients with HERr2-positive breast cancer

SABCS 2015: Adding carboplatin to presurgery chemo improved disease-free survival for patients with TNBC

SABCS 2015: Adding carboplatin to presurgery chemo improved disease-free survival for patients with TNBC

More from ecancer